Together, our data suggest that PEM-acquired resistance is strongly associated with the constitutive expression of both EGFR and HER2 protein owing to the potential genetic alteration, and the inhibition of those receptor activities may confer the PEM-acquired resistance in NSCLC cells harboring an EML4-ALK rearrangement. This evidence concerns the gene EGFR and non-small cell lung carcinoma.